Requests similar to 'Covid 19 vaccine adverse reactions in people taking TNF inhibitors'
Covid 19 vaccine adverse reactions in people taking methotrexate
Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on .
Information not held
Dear Mr Crawley,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines D...
Covid 19 vaccine adverse reactions in people on anti-coagulants
Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on .
Information not held
Dear Mr Crawley,
Please find attached the response to your FOI request.
Kind regards,
FOI Team
Vigilance and Risk Management of Medicines Division...
COVID-19 Pfizer/BioNTech mRNA Vaccine BNT162b2: toxicolgy and pharmacodynamics
Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on .
Information not held
Dear Mr Crawley,
Thank you for your email.
Please find attached response that was sent on 7 July.
Kind Regards
MHRA Customer Service Centre
Medic...
Data on pregnant women who took the covid injections
Response by Medicines and Healthcare Products Regulatory Agency to N Davies on .
Long overdue
Dear N Davies,
Please find attached our response to your FOI.
Kind regards,
FOI Team
Safety & Surveillance Group
Medicines and Healthcare Products R...
PV Strategy Document, AESI spreadsheet, Pfizer case output files
Response by Medicines and Healthcare Products Regulatory Agency to D Jackson on .
Partially successful
Internal Review of FOI 22/912
Dear D Jackson,
Thank you for your email.
Please find attached the response and attached document to your Internal Rev...
Covid-19 vaccines and atrial fibrillation
Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on .
Information not held
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
W...
Microbubble polymers in J&J COVID-19 vaccine
Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on .
Refused
Dear Mr Crawley
Regarding the questions in your request of 16 October 2021, please see
below MHRA’s response.
1. Will you confirm that mi...
Contamination, exact ingredients and WFI GMP for Pfizer's product BNT162b2
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .
Partially successful
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
W...
Safety signal reporting for Pfizer/BioNTech Covid 19 Vaccine
Response by Medicines and Healthcare Products Regulatory Agency to Mr B Kingsley on .
Partially successful
FOI 23/474
Dear Mr B Kingsley
Thank you for your email.
Please find attached the response and documentation to your FOI request.
Kind Regards
MHR...
Quality control of excipients in modRNA Pfizer and Moderna COVID-19 drugs
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .
Refused
FOI 22/476
Dear Jonathan Weissman,
Thank you for your email.
Details of the finished product specification for the finished product specifications f...
MHRA staff Covid vaccines uptake
Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on .
Information not held
Dear Graham Crawley,
Thank you for your email, please see below for our response.
Q1. Dear Medicines and Healthcare Products Regulatory Agency, How m...
Emergency Authorisation of Covid Vaccines: Criteria for End of Emergency
Response by Medicines and Healthcare Products Regulatory Agency to Branwen Sloper on .
Refused
FOI 22/412
Dear B Sloper,
Thank you for your email.
The Medicines & Healthcare products Regulatory Agency (MHRA) in the United
Kingdom (UK...
Host Cell Protein (HCP) Impurities in COVID-19 Vaccines
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .
Refused
Dear Jonathan Weissman,
Thank you for your email and we apologise for delay.
Please find attached the response to your Internal review request.
Kind...
How many deaths are too many with Pfizer BNT162B2 in order to halt deployment?
Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on .
Refused
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
W...
Section 3.2.P.1 for all approved COVID-19 vaccines
Response by Medicines and Healthcare Products Regulatory Agency to Jonathan Weissman on .
Awaiting classification
Dear Mr Weissman,
Please find our response to your request for an internal review attached.
Kind regards,
HQA FOI Team
DISCLAIMER T...
Oxford/Astrazeneca vaccine ChAdOx1-S [recombinant]: toxicolgy and pharmacodynamics
Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on .
Information not held
FOI 21/714
Dear Mr Crawley
Thank you for your email.
The temporary authorisations of the Pfizer/BioNTech, Oxford/AstraZeneca
and Moderna vacc...
COVID-19 Adverse Reaction procedures, policies and templates
Response by Medicines and Healthcare Products Regulatory Agency to D Jackson on .
Partially successful
CEC 112280
Dear Mr Jackson,
Thank you for your email.
It was thought helpful to provide the most up to date version, however, as requested, please f...
Full nucleotide base sequences for all of the COVID vaccines approved by the MRHA
Response by Medicines and Healthcare Products Regulatory Agency to Dr Lee Proctor on .
Refused
Internal Review of FOI 21/813
Dear Dr Proctor,
Thank you for your email, and your patience whilst we conducted our
internal review.
...
Auto-immune like pathology following vaccination for Covid-19
Response by Medicines and Healthcare Products Regulatory Agency to Graham Crawley on .
Refused
Thank you for your email. This auto-response is to inform you that your
email has been received and will be reviewed by our Customer Service Team.
W...
Action and inputs detailed in the briefing to the Chief Medical Officer of 25 May 2022 in respect of Evusheld
Response by NHS England to Penelope Crouch on .
Awaiting classification
Dear Penelope Crouch,
We refer to your email of 21 January 2023 in which you requested
information under the FOI Act from NHS England.
Please note...
Reports and Data to meet Conditions of Authorisation for Vaxzevria
Response by Medicines and Healthcare Products Regulatory Agency to CHP Gillow on .
Partially successful
Dear CHP Gillow
Please find attached 2 disclosure documents for Question 2 of request for
Conditions of Authorisation for Vaxzevria, request...
Further information on genotoxicity of ALC-0315 and ALC-0159
Response by Medicines and Healthcare Products Regulatory Agency to Dan Couzens on .
Successful
FOI 22/1223
Dear Mr Couzens,
Thank you your email.
We are pleased to provide you with the information requested, see below.
The UK marketing author...
When will the “COVID vaccines” complete Phase 3 clinical trials?
Response by Scottish Government to J Grove on .
Information not held
Please find attached a response to your correspondence.
**********************************************************************
This e-mail (and any...
New data kid's UK Government experimental vaccine program
Response by Medicines and Healthcare Products Regulatory Agency to [Name Removed] on .
Partially successful
Dear [Name Removed],
We have completed our Internal Review of FOI request: 21/903. Apologies
for the delay.
We note that the original...
Pfizer vaccine fertility and developmental study
Response by Medicines and Healthcare Products Regulatory Agency to J. Mwanzia on .
Successful
FOI 23/025
Dear J. Mwanzia,
Thank you for your request under FOIA, we sincerely apologise for the
delay.
The study to which you refe...